Christopher S. Destro - Net Worth and Insider Trading

Christopher S. Destro Net Worth

The estimated net worth of Christopher S. Destro is at least $2 dollars as of 2024-04-28. Christopher S. Destro is the Sr. VP, Sales and Marketing of Atossa Therapeutics Inc and owns about 1 shares of Atossa Therapeutics Inc (ATOS) stock worth over $2. Details can be seen in Christopher S. Destro's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher S. Destro has not made any transactions after 2014-05-06 and currently still holds the listed stock(s).

Transaction Summary of Christopher S. Destro

To

Christopher S. Destro Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher S. Destro owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .

Click here to see the complete history of Christopher S. Destro’s form 4 insider trades.

Insider Ownership Summary of Christopher S. Destro

Ticker Comapny Transaction Date Type of Owner
ATOS Atossa Therapeutics Inc 2015-03-16 SVP & Sales and Marketing

Christopher S. Destro Latest Holdings Summary

Christopher S. Destro currently owns a total of 1 stock. Christopher S. Destro owns 1 shares of Atossa Therapeutics Inc (ATOS) as of May 6, 2014, with a value of $2.

Latest Holdings of Christopher S. Destro

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATOS Atossa Therapeutics Inc 2014-05-06 1 1.53 2

Holding Weightings of Christopher S. Destro


Christopher S. Destro Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher S. Destro has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the sale of 0 shares on May 6, 2014, which brought Christopher S. Destro around $0.

Insider Trading History of Christopher S. Destro

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher S. Destro Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher S. Destro Ownership Network

Ownership Network List of Christopher S. Destro

No Data

Ownership Network Relation of Christopher S. Destro


Christopher S. Destro Owned Company Details

What does Atossa Therapeutics Inc do?

Who are the key executives at Atossa Therapeutics Inc?

Christopher S. Destro is the SVP & Sales and Marketing of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .

Atossa Therapeutics Inc (ATOS) Insider Trades Summary

Over the past 18 months, Christopher S. Destro made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .

In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atossa Therapeutics Inc Insider Transactions

No Available Data

Christopher S. Destro Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher S. Destro. You might contact Christopher S. Destro via mailing address: C/o Atossa Genetics Inc., 1616 Eastlake Ave. East, Suite 510, Seattle Wa 98102.

Discussions on Christopher S. Destro

No discussions yet.